INS and diabetes mellitus: All patients with pre-diabetes and 66% of transplant recipients without a diagnosis of diabetes require insulin treatment after transplantation.10 In the ERAS application recommendations, blood glucose should be targeted at 140-189 mg dL-1 during the perioperative period.11